Defend Trade Secrets Act Revolutionizes Federal Trade Secrets Practice

May 16, 2016

By: John R. Brumberg

On Wednesday, May 11, President Obama signed the Defend Trade Secrets Act (“DTSA”) into law. The DTSA revolutionizes trade secrets practice at the federal level. Its passage will likely multiply the number of trade secrets cases litigated in federal court.

We provide a few highlights:

  • First, the DTSA allows the owners of trade secrets to bring a civil action for misappropriation in federal court. Thus federal jurisdiction—premised on federal law—now exists for trade secrets claims. Before the DTSA, trade secret misappropriation was mainly a matter of state law, as Pennsylvania had adopted its own version of the Uniform Trade Secrets Act.

The DTSA subjects claims to a three-year statute of limitations, while plaintiffs can secure punitive damages of up to two times the amount of actual damages in the event of willful and malicious misappropriation. Likewise, reasonable attorney’s fees are available for the prevailing party if the trade secret was willfully and maliciously misappropriated or if the claim of misappropriation was made in bad faith.

  • Second, the DTSA provides the remedy of ex parte seizures. This allows a seizure to occur without advance notice to defendants and is the DTSA’s most controversial provision. Intended as a way to stop the dissemination of a trade secret, especially overseas, before its value has been lost through public disclosure, seizure is available only in extraordinary circumstances.
  • Third, the DTSA gives immunity to whistleblowers who disclose trade secrets to the government or in a sealed court filing. Employers must now provide notice of the DTSA’s immunity to their employees in any employee contract that governs the use of a trade secret or other confidential information. Importantly, the DTSA bars employers that do not provide this notice from recovering the exemplary damages or attorney’s fees otherwise available under the Act.
  • Fourth, the DTSA explicitly clarifies that “improper means” “does not include reverse engineering, independent derivation, or any other lawful means of acquisition.

For more information, please contact John R. Brumberg at JRB@Pietragallo.com.

News & Events

Related News

24 Pietragallo Lawyers Named in 2021 Pennsylvania Super Lawyers and Rising Stars
June 9, 2021
Including Recognition in Top 100 in Pennsylvania and Top 100 In Philadelphia Pietragallo Gordon Alfano Bosick & Raspanti, LLP is pleased to announce that 24 attorneys have been named as 2021 Super Lawyers and 2021 Rising Stars, including two attorneys who were also recognized in the Top 100 in Pennsylvania and Top 100 in Philadelphia.... Read more »
Pietragallo Team Volunteers at Mission of Mercy
July 26, 2019
Several members of the Pietragallo Gordon Alfano Bosick & Raspanti, LLP Law Firm volunteered this weekend at the Mission of Mercy Pittsburgh event. Mission of Mercy Pittsburgh, is a free, two-day dental clinic for under-served people living in Pittsburgh and the surrounding area, many of whom are from working families who do not have access... Read more »

Upcoming Events

Marc S. Raspanti to present at American Health Law Association’s Annual Meeting & In-House Counsel Program
June 29, 2026
Join partner Marc S. Raspanti at the American Health Law Association Annual Meeting & In-House Counsel Program in New York from June 27-July 1, 2026. Marc and his co-presenters will discuss “Private Equity and Health Care: Navigating the False Claims Act Risk” during two different sessions on June 29th and July 1st. Marc’s session will... Read more »
View More News & Events